25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CLCN2 Chloride Channel Mutations in Familial Hyperaldosteronism Type II

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Primary aldosteronism, a common cause of severe hypertension 1 , features constitutive production of the adrenal steroid aldosterone. We analyzed a multiplex family with familial hyperaldosteronism type II (FH-II) 2 and 80 additional probands with unsolved early-onset primary aldosteronism. Eight probands had novel heterozygous variants in CLCN2, including two de novo mutations and four independent occurrences of the identical p.Arg172Gln mutation; all relatives with early-onset primary aldosteronism carried the CLCN2 variant found in probands. CLCN2 encodes a voltage-gated chloride channel expressed in adrenal glomerulosa that opens at hyperpolarized membrane potentials. Channel opening depolarizes glomerulosa cells and induces expression of aldosterone synthase, the rate-limiting enzyme for aldosterone biosynthesis. Mutant channels cause gain of function, with higher open probabilities at the glomerulosa resting potential. These findings for the first time demonstrate a role of anion channels in glomerulosa membrane potential determination, aldosterone production and hypertension. They establish the cause of a substantial fraction of early-onset primary aldosteronism.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

          The Lancet, 380(9859), 2224-2260
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

            To develop clinical practice guidelines for the management of patients with primary aldosteronism.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

              Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K(+)) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na(+)) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca(2+)) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na(+) conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K(+) channel selectivity in constitutive cell proliferation and hormone production.
                Bookmark

                Author and article information

                Journal
                9216904
                2419
                Nat Genet
                Nat. Genet.
                Nature genetics
                1061-4036
                1546-1718
                22 December 2017
                05 February 2018
                March 2018
                05 August 2018
                : 50
                : 3
                : 349-354
                Affiliations
                [1 ]Department of Nephrology, Medical School, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
                [2 ]Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, 10117 Berlin, Germany
                [3 ]Institute of Complex Systems, Zelluläre Biophysik (ICS-4), Forschungszentrum Jülich, 52425 Jülich, Germany
                [4 ]Department of Genetics, Yale University School of Medicine, New Haven, CT 06510, USA
                [5 ]Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06510, USA
                [6 ]Yale Center for Mendelian Genomics, New Haven, CT 06510, USA
                [7 ]Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
                [8 ]Endocrine Hypertension Research Center, University of Queensland Diamantina Institute, Greenslopes and Princess Alexandra Hospitals, Brisbane, Australia
                [9 ]Proteomics Platform, Max Delbrück Center for Molecular Medicine in the Helmholtz Society and Core Unit Proteomics, Berlin Institute of Health, 13125 Berlin, Germany
                [10 ]Le Bonheur Children’s Hospital, Memphis, TN 38105, USA
                [12 ]Cooper Clinic, PA, Fort Smith, AR 72903, USA
                [12 ]Peyton Manning Children’s Hospital at St. Vincent, Indianapolis, IN 46260, USA
                [13 ]Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, MI 48109, USA
                [14 ]Division of Nephrology and Hypertension, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
                [15 ]Olin Teague Veterans Administration Hospital, Temple, TX 76504, USA
                [16 ]Division of Endocrinology, Nemours Children’s Specialty Care, Jacksonville, FL 32207, USA
                [17 ]Laboratory of Human Genetics and Genomics, The Rockefeller University, New York, NY 10065, USA
                Author notes
                [* ] Correspondence and material requests should be addressed to: Ute I. Scholl, M.D., BIH Johanna Quandt Professorship for Hypertension and Molecular Biology of Endocrine Tumors, Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany. Telephone: +49-30-450-543080, Fax +49-211-81-015-04086, ute.scholl@ 123456charite.de
                [#]

                These authors contributed equally.

                Article
                NIHMS929906
                10.1038/s41588-018-0048-5
                5862758
                29403011
                f22829e9-b19e-4a12-bc1f-aeff87ae05bb

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Genetics
                Genetics

                Comments

                Comment on this article